Lyell Immunopharma

LYEL · NASDAQ

$9.70+$0.90 (+10.23%)TodayMarket closed ·
Prev close $8.80

Who owns LYEL

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 66.8% of LYEL’s shares.

  • ARCH Venture Partners13.9%
  • Innovative Cellular Therapeutics Holdings Ltd11.9%
  • Gates Frontier, L.L.C.6.6%
  • Explore Investments LLC6.6%
  • Next 6 largest institutions27.8%
  • All other shareholders33.2%
Top institutional holders of LYEL
HolderShares% of shares
ARCH Venture Partners3.25M13.92%
Innovative Cellular Therapeutics Holdings Ltd2.77M11.89%
Gates Frontier, L.L.C.1.53M6.55%
Explore Investments LLC1.53M6.55%
GSK plc1.51M6.48%
Euler Managers Ltd1.43M6.11%
Milky Way Investments Group Ltd1.01M4.32%
MWG Management, Ltd.1.01M4.32%
Vanguard Capital Management, LLC786.77K3.37%
Orland Properties Ltd754.70K3.23%

Largest mutual fund holders

Top mutual fund holders of LYEL
HolderShares% of shares
Vanguard Total Stock Market Index Fund604.46K2.59%
iShares Russell 2000 ETF225.98K0.97%
Vanguard Extended Market Index Fund163.75K0.70%
Fidelity Small Cap Index Fund102.68K0.44%
iShares Russell 2000 Value ETF88.93K0.38%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $255.52K (16 trades) of LYEL on the open market, with no buys.

Latest LYEL insider transactions
InsiderTypeSharesValue
Aguirre Jarrad MattieuSale422$3.64K
Aguirre Jarrad MattieuAward47.50K—
Shook DavidSale500$6.35K
Lee Gary K.Sale1.46K$22.64K
Hill Stephen J.Sale989$15.37K
Seely LynnSale9.59K$149.01K
Bulis Veronica SanchezSale621$8.91K
Lee Gary K.Sale131$1.88K
Hill Stephen J.Sale89$1.28K
Seely LynnSale390$5.59K

Short interest

Settled Sep 30, 2026

Shares short
1.26M
Days to cover
7.40
% of shares outstanding
5.42%
Average daily volume
170.78K
Change since last report
+6.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.